ARTICLE | Company News
Anavex, Biogen deal
October 10, 2016 7:00 AM UTC
Biogen will test Anavex’s ANAVEX 2-73 in an oligodendrocyte precursor cell differentiation assay. The assay may lead to an in vivo remyelination trial using a chemical demyelination model. ANAVEX 2-7...